title: Monitoring of anticoagulant effects of dabigatran in everyday practice: first experience in 32 Polish patients.
authors.forename: Urszula
authors.initials: U
authors.lastname: Czubek
authors.forename: Tadeusz
authors.initials: T
authors.lastname: Góralczyk
authors.forename: Jarosław
authors.initials: J
authors.lastname: Zalewski
authors.forename: Anetta
authors.initials: A
authors.lastname: Undas
mesh_terms: D000368:Aged; D000991:Antithrombins / Q000097:blood* / Q000627:therapeutic use*; D001281:Atrial Fibrillation / Q000188:drug therapy*; D001562:Benzimidazoles / Q000097:blood* / Q000627:therapeutic use*; D000069604:Dabigatran; D016903:Drug Monitoring / Q000379:methods*; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D011044:Poland; D010818:Practice Patterns, Physicians'; D015091:beta-Alanine / Q000031:analogs & derivatives* / Q000097:blood / Q000627:therapeutic use
chemical_list: D000991:Antithrombins; D001562:Benzimidazoles; D015091:beta-Alanine; D000069604:Dabigatran